Ivor Royston
2020
In 2020, Ivor Royston earned a total compensation of $744.2K as President and Chief Executive Officer at Sunesis Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $285,525 |
|---|---|
| Salary | $448,200 |
| Other | $10,456 |
| Total | $744,181 |
Royston received $448.2K in salary, accounting for 60% of the total pay in 2020.
Royston also received $285.5K in non-equity incentive plan and $10.5K in other compensation.
Rankings
In 2020, Ivor Royston's compensation ranked 9,757th out of 13,090 executives tracked by ExecPay. In other words, Royston earned more than 25.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,757 out of 13,090 | 26th |
Division Manufacturing | 4,196 out of 5,620 | 25th |
Major group Chemicals And Allied Products | 1,722 out of 2,253 | 24th |
Industry group Drugs | 1,509 out of 1,953 | 23rd |
Industry Pharmaceutical Preparations | 1,113 out of 1,458 | 24th |
Source: SEC filing on April 27, 2022.
Royston's colleagues
We found two more compensation records of executives who worked with Ivor Royston at Sunesis Pharmaceuticals in 2020.